TOKC proudly supports The RACE for Children Act

TOKC supports The RACE for Children Act

Children’s cancer is the number one disease killer of children. However, it is challenging for children to get access to the most promising and novel cancer drugs available to adults.

The RACE for Children Act, which is an update of the Pediatric Research Equity Act (PREA), is the game changer that children’s cancer desperately needs.

Here are the basics:

The Problem

PREA requires companies developing drugs for adults to also develop them for children. However, contrary to Congressional intent, PREA has never applied to cancer because children’s cancers occur in different organs than do adult cancers.

The Solution

The RACE for Children Act would authorize the FDA to require PREA pediatric studies when a molecular target of an adult cancer drug is relevant to a children’s cancer. It would end the orphan exemption for PREA studies. Every newly approved cancer drug has enjoyed this exemption over the past three years.

The bill was introduced by Sens. Michael Bennet (D-Colo.) and Marco Rubio (R-Fla.), and Reps. Michael McCaul (R-Texas), G. K. Butterfield (D-N.C.), Sean Duffy (R-Wisc.), and Chris Van Hollen (D-Md.).

Triumph Over Kid Cancer Foundation supports The RACE for Children Act, which could give the 43 children diagnosed with cancer every day a chance to see another tomorrow. The bill is also backed by more than 100 pediatric cancer advocacy groups, including Kids v Cancer.